Ethnic and sex differences in adiponectin: From childhood to adulthood

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 12, 2016, Pages 4808-4815

  Ohman Hanson, Rebecca A ^a   Cree Green, Melanie ^a   Kelsey, Megan M ^a   Bessesen, Daniel H ^a   Sharp, Teresa A ^b   Pyle, Laura ^c,d   Pereira, Rocio I ^a   Nadeau, Kristen J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTHERN COLORADO   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

^d Food Science and Human Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; ADIPOQ PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HISPANIC; HUMAN; INSULIN RESISTANCE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBERTY; SEX DIFFERENCE; BLOOD; CAUCASIAN; COLORADO; ETHNOLOGY; HUMAN DEVELOPMENT; MIDDLE AGED; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADIPONECTIN; ADOLESCENT; ADULT; CHILD; COLORADO; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMAN DEVELOPMENT; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PUBERTY; SEX FACTORS; YOUNG ADULT;

EID: 85003749575     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1137     Document Type: Article

References (40)

1. Crawford PB, Story M, Wang MC, Ritchie LD, Sabry ZI. Ethnic issues in the epidemiology of childhood obesity. Pediatr Clin North Am. 2001;48:855-878
2. Mather KJ, Funahashi T, Matsuzawa Y, et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes. 2008;57:980-986
3. Ho RC, Davy KP, Hickey MS, Summers SA, Melby CL. Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans. Am J Pshysiol Endocrinol Metab. 2002;283: E799-E808
4. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47
5. Rosenbaum M, Fennoy I, Accacha S, et al. Racial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children. Obesity. 2013;21(10):2081-2090
6. Copeland KC, Zeitler P, Geffner M, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1):159-167
7. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746-26749
8. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-1935
9. Weiss R, Taksali SE, Dufour S, et al. The "obese insulin-sensitive" adolescent: Importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab. 2005;90:3731-3737
10. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89: 2563-2568
11. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-B signaling through a cAMP-dependent pathway. Circulation. 2000;102:1296-1301
12. Magge SN, Stettler N, Koren D, et al. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. J Clin Endocrinol Metab. 2011;96(5): 1549-1554
13. Rigamonti AE, Agosti F, De Col A, et al. Severely obese adolescents and adults exhibit a different association of circulating levels of adipokines and leukocyte expression of the related receptors with insulin resistance. Int J Endocrinol. 2013;2013:1-12
14. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51:2734-2741
15. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, Saha C, Pratt JH, Considine RV. Lower serum adiponectin levels in African American boys. Obesity Res. 2003;11(11):1384-1390
16. Hanley AJ, Bowden D, Wagenknecht LE, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and African-Americans. J Clin Endocrinol Metab. 2007;92(7):2665-2671
17. Bacha F, Gungor N, Saad R, Arslanian SA. Adiponectin in youth: Relationship to visceral adiposity, insulin sensitivity, and-cell function. Diabetes Care. 2004;27(2):547-552
18. Shaibi GQ, Cruz ML, Weigensberg MJ, et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab. 2007;92(5):1809-1813
19. Riestra P, Garcia-Anguita A, Ortega L, Garces C. Relationship of adiponectin with sex hormone levels in adolescents. Horm Res Pediatr. 2013;79:83-87
20. Böttner A, Kratzsch J, Müller G, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 2004; 89:4053-4061
21. Pérez CM, Ortiz AP, Fuentes-Mattei E, et al. High prevalence of cardiometabolic risk factors in Hispanic adolescents: Correlations with adipocytokines and markers of inflammation. J Immigr Minor Health. 2014;16:865-873
22. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression of type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126-1133
23. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57-58
24. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;50:1884-1888
25. Hulver MW, Saleh O, MacDonald K, Pories W, Barakat HA. Ethnic differences in adiponectin levels. Metabolism. 2004;52(1):1-3
26. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes. 2005; 54:2772-2778
27. Schutte AE, Huisman HW, Schutte R, et al. Differences and similarities regarding adiponectin investigated in African-American and Caucasian women. Eur J Endocriol. 2007;157:181-188
28. Pereira RI, Wang C, Hosokawa P, et al. Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMC Endocr Disord. 2011;11(13):1-9
29. Lee S, Bacha F, Gungor N, Arslanian S. Racial differences in adiponectin in youth: Relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006;29(1):51-56
30. Martos-Moreno GA, Barrios V, Argente J. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: Relationship with sex steroids. Eur J Endocrinol. 2006;155:429-434
31. Lu X, Ming L, Yin J, et al. Change of body composition and adipokines and their relationship with insulin resistance across pubertal development in obese and non-obese Chinese children: The BCAMS study. Int J Endocrinol. 2012;1-10
32. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-1495
33. Moran A, JacobsDRJr, Steinberger J, et al. Insulin resistance during puberty: Results from clamp studies in 357 children. Diabetes. 1999; 48:2039-2044
34. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50(11):2444-2450
35. Tworoger SS, Mantzoros C, Hankinson SE. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity. 2007;15:2217-2224
36. Winters SJ, Gogineni J, Karegar M, et al. Sex hormone-binding globulin gene expression and insulin resistance. J Clin Endocrinol Metab. 2014;99(12):E2780-E2788
37. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359
38. King GA, Deemer SE, Thompson DL. Relationship between leptin, adiponectin, bone mineral density, and measures of adiposity among pre-menopausal Hispanic and Caucasian women. Endocr Res. 2010;35(3):106-117
39. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595-2600
40. Wolfgram PM, Connor EL, Rehm JL, Eickhoff JC, Reeder SB, Allen DB. Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls. Obesity. 2014; 22(1):243-248.